May 2025

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the May 2025 cover story of Contemporary Pediatrics.

Even before the change in national leadership, access to adolescent gender-affirming care was becoming more difficult, with many barriers faced by these at-risk patients.

Current prevention strategies include 2 injectables for infants and young children, namely palivizumab and nirsevimab.

Research shows that nearly 80% of foster children have at least 1 significant mental health need.

The federal agencies are encouraging companies to develop new infant formulas and clarify opportunities to inform consumers about formula ingredients.

Prior to approval on February 14, 2025, the only FDA approved vaccine for chikungunya protection was indicated for 18 years and up.

A study finds air lead exposure increases infant mortality, linking emissions to low birthweight, SUID, and respiratory issues, urging stricter regulations.